Both NFI and TSC2 are tumor suppressor genes associated with autosomal dominant tumor predisposition syndromes that increase the risk for CNS neoplasms in addition to a constellation of other syndromic features [52,53]. This evidence concerns the gene TSC2 and central nervous system neoplasm.